Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

TIDI addresses uncertainty but not indeterminism.

Coory M.

Value Health. 2013 Jan-Feb;16(1):215-6. doi: 10.1016/j.jval.2012.08.2225. No abstract available.

2.

Transparent interactive decision interrogator-reply to letter to the editor by Michael Coory.

Bujkiewicz S, Sutton AJ, Abrams KR, Cooper NJ, Spiegelhalter DJ.

Value Health. 2013 Jan-Feb;16(1):216-7. doi: 10.1016/j.jval.2012.10.014. No abstract available.

3.

Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care.

Bujkiewicz S, Jones HE, Lai MC, Cooper NJ, Hawkins N, Squires H, Abrams KR, Spiegelhalter DJ, Sutton AJ.

Value Health. 2011 Jul-Aug;14(5):768-76. doi: 10.1016/j.jval.2010.12.002. Epub 2011 Apr 30.

4.

Eliciting and combining subjective judgments about uncertainty.

Wolpert RL.

Int J Technol Assess Health Care. 1989;5(4):537-57.

PMID:
2699470
5.
6.

Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.

Chilcott J, Tappenden P, Rawdin A, Johnson M, Kaltenthaler E, Paisley S, Papaioannou D, Shippam A.

Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250. Review.

7.

Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M, Brazier J, O'Hagan T.

Health Econ. 2005 Apr;14(4):339-47.

PMID:
15736142
8.

An introduction to the methods of cost-effectiveness analysis.

[No authors listed]

Drug Ther Bull. 2012 Jul;50(7):81-4. doi: 10.1136/dtb.2012.06.0118.

PMID:
22789768
9.

Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J.

Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. Review.

10.

Evidence-based decision-making within Australia's pharmaceutical benefits scheme.

Lopert R.

Issue Brief (Commonw Fund). 2009 Jul;60:1-13.

PMID:
19639714
11.

Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.

Xie F, Bowen JM, Sutherland SC, Burke N, Blackhouse G, Tarride JE, O'Reilly D, Goeree R.

Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):513-21. doi: 10.1586/erp.11.60.

PMID:
21958096
12.

Policy making and roles of health technology assessment.

Tantivess S.

J Med Assoc Thai. 2008 Jun;91 Suppl 2:S88-99.

PMID:
19253491
13.

Development of an evidence-based specialty support surface decision tool.

Wall S, Hunter K, Coleman-Miller G.

Ostomy Wound Manage. 2005 Feb;51(2):80-6.

14.

Health technology assessment and clinical decision making: which is the best evidence?

Granados A.

Int J Technol Assess Health Care. 1999 Summer;15(3):585-92.

PMID:
10874384
15.

The economic valuation of improved process plant decision support technology.

White DC.

ISA Trans. 2007 Jun;46(3):437-42. Epub 2007 Apr 16.

PMID:
17434170
16.

Coverage with evidence development: a very good beginning, but much to be done. Commentary to Hutton et al.

Tunis SR, Chalkidou K.

Int J Technol Assess Health Care. 2007 Fall;23(4):432-5. No abstract available.

PMID:
17937830
17.

National Authority for Health: France.

Rochaix L, Xerri B.

Issue Brief (Commonw Fund). 2009 Jul;58:1-9.

PMID:
19639712
18.

Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables.

Baltussen RM, Hutubessy RC, Evans DB, Murray CJ.

Int J Technol Assess Health Care. 2002 Winter;18(1):112-9.

PMID:
11987434
19.
20.

A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.

Claxton K, Ginnelly L, Sculpher M, Philips Z, Palmer S.

Health Technol Assess. 2004 Jul;8(31):1-103, iii.

Supplemental Content

Support Center